Adult attention deficit hyperactivity symptoms and psychosis: Epidemiological evidence from a population survey in England

Psychiatry Research

Volumn 229, Issue 1-2, 2015, Pages 49-56

  Marwaha, Steven ^a,b   Thompson, Andrew ^a   Bebbington, Paul ^c   Singh, Swaran P ^a   Freeman, Daniel ^d   Winsper, Catherine ^a   Broome, Matthew R ^a,d,e  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Early Intervention Service   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

ADHD; Cannabis; Cocaine; Depression; Psychosis

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CANNABIS; COCAINE; ILLICIT DRUG; METHYLPHENIDATE; STREET DRUG;

ADHD SELF REPORT SCALE; ADOLESCENT; ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; AUDITORY HALLUCINATION; AUTISM; CONDUCT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; DYSPHORIA; HUMAN; HYPOMANIA; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; PARANOIA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SCORING SYSTEM; UNITED KINGDOM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER; ENGLAND; FEMALE; HALLUCINATIONS; HEALTH SURVEY; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAUSALITY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; ENGLAND; FEMALE; HALLUCINATIONS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84939470808     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.07.075     Document Type: Article

References (59)

1. Adler L., Kessler R.C., Spencer T. Adult ADHD Self-Report Scale-v1. 1 (ASRS-v1. 1) Symptom Checklist 2003, World Health Organization, Geneva.
2. Barkley R.A., Fischer M., Smallish L., Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J. Abnorm. Psychol. 2002, 111:279-289.
3. Baron-Cohen S., Wheelwright S., Skinner R., Martin J., Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, malesand females, scientists and mathematicians. J. Autism Dev. Disord. 2001, 31:5-17.
4. Barr W.B. Schizophrenia and attention deficit disorder. Ann. N. Y. Acad. Sci. 2001, 931:239-250.
5. Bebbington P., Nayani T. The psychosis screening questionnaire. Int. J. Methods Psychiatr. Res. 1995, 5:11-20.
6. Bebbington P.E., Bhugra D., Brugha T., Singleton N., Farrell M., Jenkins R., Lewis G., Meltzer H. Psychosis, victimisation and childhood disadvantage evidence from the second British national survey of psychiatric morbidity. Br. J. Psychiatry 2004, 185:220-226.
7. Berman I., Viegner B., Merson A., Allan E., Pappas D., Green A.I. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr. Res. 1997, 25:1-10.
8. Biederman J., Mick E., Faraone S.V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am. J. Psychiatry 2000, 157:816-818.
9. Biederman J., Monuteaux M.C., Mick E., Spencer T., Wilens T.E., Silva J.M., Snyder L.E., Faraone S.V. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol. Med. 2006, 36:167-180.
10. Bolea-Alamañac B., Nutt D.J., Adamou M., Asherson P., Bazire S., Coghill D., Heal D., Müller U., Nash J., Santosh P. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British association for psychopharmacology. J. Psychopharmacol. 2014, 28:179-203.
11. Brugha T.S., Bebbington P.E., Singleton N., Melzer D., Jenkins R., Lewis G., Farrell M., Bhugra D., Lee A., Meltzer H. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br. J. Psychiatry 2004, 185:378-384.
12. Caspi A., Houts R.M., Belsky D.W., Goldman-Mellor S.J., Harrington H., Israel S., Meier M.H., Ramrakha S., Shalev I., Poulton R. The P factor: one general psychopathology factor in the structure of psychiatric disorders?. Clin. Psychol. Sci. 2013, 2:119-137.
13. Catone G., Marwaha S., Kuipers E., Lennox B., Freeman D., Bebbington P., Broome M. Bullying victimisation and risk of psychotic phenomena: analyses of British national survey data. Lancet Psychiatry 2015, 2:618-624.
14. Cheung C., Yu K., Fung G., Leung M., Wong C., Li Q., Sham P., Chua S., McAlonan G. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One 2010, 5:e12233.
15. Dalsgaard S., Mortensen P.B., Frydenberg M., Maibing C.M., Nordentoft M., Thomsen P.H. Association between attention-deficit hyperactivity disorder in childhood and schizophrenia later in adulthood. Eur. Psychiatry 2013, 29:259-263.
16. Ekinci O., Sabuncuoglu O. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35:648-649.
17. Faraone S.V., Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J. Atten. Disord. 2005, 9:384-391.
18. Faraone S.V., Biederman J., Spencer T., Wilens T., Seidman L.J., Mick E., Doyle A.E. Attention-deficit/hyperactivity disorder in adults: an overview. Biol. Psychiatry 2000, 48:9-20.
19. Faraone S.V., Wilens T.E., Petty C., Antshel K., Spencer T., Biederman J. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am. J. Addict. 2007, 16:24-34.
20. Fisher H.L., Jones P.B., Fearon P., Craig T.K., Dazzan P., Morgan K., Hutchinson G., Doody G.A., McGuffin P., Leff J. The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder. Psychol. Med. 2010, 40:1967-1978.
21. Freeman D., Dunn G., Fowler D., Bebbington P., Kuipers E., Emsley R., Jolley S., Garety P. Current paranoid thinking in patients with delusions: the presence of cognitive-affective biases. Schizophr. Bull. 2013, 39:1281-1287.
22. Freeman D., McManus S., Brugha T., Meltzer H., Jenkins R., Bebbington P. Concomitants of paranoia in the general population. Psychol. Med. 2011, 41:923-936.
23. Garety P., Kuipers E., Fowler D., Freeman D., Bebbington P. A cognitive model of the positive symptoms of psychosis. Psychol. Med. 2001, 31:189-196.
24. Gau S.S.-F., Lin Y.-J., Cheng A.T.-A., Chiu Y.-N., Tsai W.-C., Soong W.-T. Psychopathology and symptom remission at adolescence among children with attention-deficit-hyperactivity disorder. Aust. N. Z. J. Psychiatry 2010, 44:323-332.
25. Hamshere M.L., Stergiakouli E., Langley K., Martin J., Holmans P., Kent L., Owen M.J., Gill M., Thapar A., O'Donovan M., Craddock N. A shared polygenic contribution between childhood ADHD and adult schizophrenia. Br. J. Psychiatry 2013, 203:107-111.
26. Hoptman M.J., D'Angelo D., Catalano D., Mauro C.J., Shehzad Z.E., Kelly A.C., Castellanos F.X., Javitt D.C., Milham M.P. Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophr. Bull. 2010, 36:1020-1028.
27. Howes O.D., Murray R.M. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet 2014, 383:10.
28. Kaladjian A., Jeanningros R., Azorin J., Anton J., Mazzola-Pomietto P. Impulsivity and neural correlates of response inhibition in schizophrenia. Psychol. Med. 2011, 41:291-299.
29. Karlson K.B., Holm A., Breen R. Comparing regression coefficients between same-sample nested models using logit and probit: a new method. Sociol. Methodol. 2012, 42:286-313.
30. Keefe R.S., Silverman J.M., Mohs R.C., Siever L.J., Harvey P.D., Friedman L., Lees Roitman S.E., DuPre R.L., Smith C.J., Schmeidler J. Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch. Gen. Psychiatry 1997, 54:169-176.
31. Kelleher I., Connor D., Clarke M.C., Devlin N., Harley M., Cannon M. Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol. Med. 2012, 42:1857-1863.
32. Keshavan M.S., Sujata M., Mehra A., Montrose D.M., Sweeney J.A. Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophr. Res. 2003, 59:85-92.
33. Kessler R.C., Adler L., Ames M., Demler O., Faraone S., Hiripi E., Howes M.J., Jin R., Secnik K., Spencer T. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol. Med. 2005, 35:245-256.
34. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., Faraone S.V., Greenhill L.L., Howes M.J., Secnik K. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am. J. Psychiatry 2006, 163:716-723.
35. Kessler R.C., Adler L.A., Gruber M.J., Sarawate C.A., Spencer T., Van Brunt D.L. Validity of the World Health Organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. Int. J. Methods Psychiatr. Res. 2007, 16:52-65.
36. Levy F., Swanson J.M. Timing, space and ADHD: the dopamine theory revisited. Aust. N. Z. J. Psychiatry 2001, 35:504-511.
37. Lewis G., Pelosi A.J., Araya R., Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol. Med. 1992, 22:465-486.
38. Marwaha S., Broome M.R., Bebbington P.E., Kuipers E., Freeman D. Mood instability and psychosis: analyses of British national survey data. Schizophr. Bull. 2014, 40:269-277.
39. McGough J.J., Smalley S.L., McCracken J.T., Yang M., Del'Homme M., Lynn D.E., Loo S. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am. J. Psychiatry 2005, 162:1621-1627.
40. McManus S., Meltzer H., Brugha T.S., Bebbington P.E., Jenkins R. Adult Psychiatric Morbidity in England, 2007: Results of a Household Survey 2009, The NHS Information Centre for Health and Social Care, London.
41. Mehler-Wex C., Riederer P., Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 2006, 10:167-179.
42. Miller T.W., Nigg J.T., Faraone S.V. Axis I and II comorbidity in adults with ADHD. J. Abnorm. Psychol. 2007, 116:519-528.
43. Morton W.A., Stockton G.G. Methylphenidate abuse and psychiatric side effects. Prim. Care Companion J. Clin. Psychiatry 2000, 2:159-164.
44. Mosholder A.D., Gelperin K., Hammad T.A., Phelan K., Johann-Liang R. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics 2009, 123:611-616.
45. Nelson H.E., O'Connell A. Dementia: the estimation of premorbid intelligence levels using the new adult reading test. Cortex 1978, 14:234-244.
46. Owen M.J., O'Donovan M.C., Thapar A., Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 2011, 198:173-175.
47. Pukrop R., Klosterkötter E. Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence. Neurotox. Res. 2010, 18:272-286.
48. Qassem T., Bebbington P., Spiers N., McManus S., Jenkins R., Dein S. Prevalence of psychosis in black ethnic minorities in Britain: analysis based on three national surveys. Soc. Psychiatry Psychiatr. Epidemiol. 2014, 50:1057-1064.
49. Ross R. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am. J. Psychiatry 2006, 163:1149-1152.
50. Ross R.G., Heinlein S., Tregellas H. High rates of comorbidity are found in childhood-onset schizophrenia. Schizophr. Res. 2006, 88:90-95.
51. Rubia K. The dynamic approach to neurodevelopmental psychiatric disorders: use of fMRI combined with neuropsychology to elucidate the dynamics of psychiatric disorders, exemplified in ADHD and schizophrenia. Behav. Brain Res. 2002, 130:47-56.
52. Schatz D.B., Rostain A.L. ADHD with comorbid anxiety a review of the current literature. J. Atten. Disord. 2006, 10:141-149.
53. Shah P.J., Morton M.J.S. Adults with attention-deficit hyperactivity disorder-diagnosis or normality?. Br. J. Psychiatry 2013, 203:317-319.
54. Sim K., Chua T.H., Chan Y.H., Mahendran R., Chong S.A. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study. J. Psychiatr. Res. 2006, 40:656-663.
55. Washbrook E., Propper C., Sayal K. Pre-school hyperactivity/attention problems and educational outcomes in adolescence: prospective longitudinal study. Br. J. Psychiatry 2013, 203:265-271.
56. Weiss G., Hechtman L., Milroy T., Perlman T. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J. Am. Acad. Child Psychiatry 1985, 24:211-220.
57. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., Stefansson H., Stefansson K., Magnusson P., Gudmundsson O.O., Gustafsson O., Holmans P., Owen M.J., O'Donovan M., Thapar A. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
58. Wingo A.P., Ghaemi S.N. A systematic review of rates and diagnostic validity of comorbid adult attention-deficit/hyperactivity disorder and bipolar disorder. J. Clin. Psychiatry 2007, 68(11):1776-1784.
59. World Health Organization SCAN: Schedules for Clinical Assessment in Neuropsychiatry 1992, WHO, Geneva.